Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2025-12-24 @ 9:42 PM
NCT ID:
NCT01471132
Eligibility Criteria:
Inclusion Criteria:
* Histologically proved gastric adenocarcinoma.
* Peritoneum metastasis is observed or suspected by laparoscopy or radiologic examination,or free cancer cells are detected in peritoneal lavage liquid.
* Potentially resectable gastric cancer.
* ALT, AST \< 80U/L; Total Bilirubin \< 30μmol/L; WBC \> 4x10\^9/L; PLT \> 100x10\^9/L; Cr \< 1.5 fold normal value.
* ECOG 0-2 points.
* Expected survival time longer than 3 months.
* Informed consent.
Exclusion Criteria:
* Recurrent gastric cancer.
* Pregnant or lactating women.
* Allergic to oxaliplatin or paclitaxel.
* Abnormal liver/kidney function.
* Serious heart/metabolic disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01471132
Study Brief:
Protocol Section:
NCT01471132